Table 2. Predictors for elevated troponin in presence of COVID-19 diagnosis.
Adj. OR a (95% CI b) | p-value | |
---|---|---|
Age | 1.04 (1.01,1.06) | 0.002 |
Sex = Male | 0.33 (0.16,0.65) | 0.002 |
SBP c <90 mmHg | 5.91 (2.42,14.44) | < 0.001 |
Creatinine c | 2.88 (1.44,5.73) | 0.003 |
Atrial Fibrillation | 1.06 (0.39,2.88) | 0.913 |
Ischemic Heart Disease | 1.81 (0.72,4.55) | 0.205 |
Heart Failure | 1.98 (0.69,5.72) | 0.207 |
Chronic Kidney Disease | 0.86 (0.31,2.4) | 0.77 |
Diabetes Mellitus | 0.93 (0.44,1.95) | 0.849 |
Cerebrovascular Accident | 1.01 (0.35,2.88) | 0.986 |
Hypertension | 0.97 (0.48,1.96) | 0.931 |
Beta Blockers Therapy | 1.24 (0.58,2.63) | 0.582 |
ACEI d / ARB e Therapy | 1.45 (0.54,3.85) | 0.458 |
HMG CoA reductase inhibitors | 1.03 (0.5,2.11) | 0.93 |
C-Reactive Protein c | 1 (1,1.01) | 0.354 |
Lymphopenia c | 1.4 (0.73,2.68) | 0.306 |
a adjusted odds ratio
b confidence interval
c Measured within 24-hours from admission
d angiotensin-converting-enzyme inhibitors
e angiotensin II receptor blocker